Cambridge Investment Research Advisors’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.94M Sell
44,023
-5,238
-11% -$924K 0.01% 932
2026
Q1
$8.84M Sell
49,261
-7,452
-13% -$1.27M 0.02% 664
2025
Q4
$8.02M Buy
56,713
+4,687
+9% +$532K 0.02% 678
2025
Q3
$4.22M Buy
52,026
+2,606
+5% +$201K 0.01% 1010
2025
Q2
$3.1M Buy
49,420
+5,879
+14% +$348K 0.01% 1128
2025
Q1
$3.14M Buy
43,541
+8,572
+25% +$698K 0.01% 1063
2024
Q4
$3.01M Sell
34,969
-5,245
-13% -$522K 0.01% 1093
2024
Q3
$3.81M Sell
40,214
-2,393
-6% -$212K 0.01% 957
2024
Q2
$4.07M Sell
42,607
-47
-0.1% -$5.59K 0.02% 864
2024
Q1
$5.62M Sell
42,654
-7,141
-14% -$879K 0.02% 688
2023
Q4
$7.19M Sell
49,795
-1,349
-3% -$185K 0.03% 544
2023
Q3
$8.7M Buy
51,144
+9,833
+24% +$1.96M 0.04% 426
2023
Q2
$9.22M Buy
41,311
+13,071
+46% +$2.67M 0.04% 409
2023
Q1
$6.24M Buy
28,240
+4,691
+20% +$1.16M 0.03% 531
2022
Q4
$5.11M Buy
23,549
+3,057
+15% +$815K 0.03% 601
2022
Q3
$5.42M Buy
20,492
+1,108
+6% +$282K 0.03% 535
2022
Q2
$4.05M Sell
19,384
-1,728
-8% -$385K 0.02% 679
2022
Q1
$4.67M Sell
21,112
-5,484
-21% -$1.16M 0.02% 667
2021
Q4
$6.22M Sell
26,596
-6,830
-20% -$1.69M 0.03% 556
2021
Q3
$7.32M Buy
33,426
+7,387
+28% +$1.58M 0.04% 457
2021
Q2
$4.39M Sell
26,039
-1,693
-6% -$273K 0.02% 687
2021
Q1
$4.05M Buy
27,732
+4,376
+19% +$702K 0.02% 653
2020
Q4
$3.44M Buy
23,356
+7,441
+47% +$883K 0.02% 656
2020
Q3
$1.42M Buy
15,915
+1,776
+13% +$157K 0.01% 987
2020
Q2
$1.09M Buy
14,139
+2,549
+22% +$173K 0.01% 1079
2020
Q1
$653K Buy
11,590
+632
+6% +$48.4K 0.01% 1214
2019
Q4
$800K Sell
10,958
-970
-8% -$64.8K 0.01% 1286
2019
Q3
$829K Sell
11,928
-913
-7% -$62.2K 0.01% 1183
2019
Q2
$904K Buy
12,841
+3,911
+44% +$289K 0.01% 1070
2019
Q1
$732K Buy
8,930
+570
+7% +$46.6K 0.01% 1231
2018
Q4
$644K Sell
8,360
-1,730
-17% -$163K 0.01% 1186
2018
Q3
$1.01M Buy
10,090
+2,539
+34% +$246K 0.01% 1022
2018
Q2
$712K Buy
7,551
+118
+2% +$11.3K 0.01% 1192
2018
Q1
$689K Sell
7,433
-1,637
-18% -$180K 0.01% 1148
2017
Q4
$1.16M Buy
9,070
+3,010
+50% +$408K 0.01% 829
2017
Q3
$826K Buy
6,060
+2,400
+66% +$285K 0.01% 937
2017
Q2
$386K Buy
+3,660
New +$398K 0.01% 1366
2013
Q3
Sell
-3,859
Closed -$240K 1197
2013
Q2
$240K Buy
+3,859
New +$242K 0.01% 860

Other funds holding ALB

Cambridge Investment Research Advisors's ALB Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Albemarle (ALB) stake by 11% in Q2 2026, selling an estimated $924K and leaving 44,023 shares worth $5.94M. The position accounts for 0.01% of the portfolio, ranked #932.

Cambridge Investment Research Advisors first reported a position in ALB in Q2 2013 and has held it in 38 quarters since. The position peaked at $9.22M in Q2 2023. 937 funds tracked by Wall St. Rank hold ALB as of Q2 2026.

  • Cambridge Investment Research Advisors held 44,023 shares of Albemarle worth $5.94M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 5,238 Albemarle shares in Q2 2026, an estimated $924K.
  • Albemarle made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #932 holding.
  • Cambridge Investment Research Advisors first reported a position in Albemarle in Q2 2013 and has held it in 38 quarters since.
  • Cambridge Investment Research Advisors's Albemarle position peaked at $9.22M in Q2 2023.
  • 937 funds tracked by Wall St. Rank held Albemarle as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.